Recent advances in congenital heart disease genomics

Anna Wilsdon1, Alejandro Sifrim2, Marc-Phillip Hitz2

  • 1School of Life Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.

F1000Research
|July 1, 2017
PubMed

Insights

Advances in genetic research are uncovering new causes of congenital heart disease (CHD). This helps understand inheritance risks and improve lifelong care for affected individuals.

Area of Science:

  • Cardiovascular Genetics
  • Developmental Biology
  • Medical Genetics

Background:

  • Congenital heart disease (CHD) is the most common birth defect, with increasing survival rates due to medical advancements.
  • Growing numbers of patients require lifelong care, raising questions about genetic inheritance and recurrence risks.
  • Previous genetic discoveries were mainly from Mendelian inheritance studies.

Purpose of the Study:

  • To discuss recent advances in understanding the genetic basis of congenital heart disease.
  • To explore the implications of novel gene discoveries for patient care and genetic counseling.
  • To highlight challenges and future directions in CHD genetics research.

Main Methods:

  • Large-scale DNA sequencing of patient cohorts with congenital heart disease.
  • Analysis of genetic data to identify novel genes and mechanisms.
  • Review of current literature on CHD genetics and clinical implications.

Main Results:

  • Novel gene discoveries are providing fresh insights into CHD etiology.
  • Identification of diverse genetic mechanisms underlying isolated and syndromic CHD.
  • Enhanced understanding of the genetic architecture of congenital heart defects.

Conclusions:

  • Recent genetic research significantly advances the understanding of CHD.
  • New genetic insights have direct implications for patient management and family planning.
  • Close collaboration between clinicians and researchers is crucial for future progress in CHD genetics.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.6K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
59
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
721